Detalles de la búsqueda
1.
Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions.
Infection
; 49(4): 785-788, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963523
2.
[Acute Facial Swelling Following Dental Procedure - an Allergic Reaction?] / Akute Gesichtsschwellung nach Zahnbehandlung: eine allergische Reaktion?
Anasthesiol Intensivmed Notfallmed Schmerzther
; 54(6): 435-438, 2019 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-31212334
3.
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
Int J Cancer
; 137(3): 678-85, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530271
4.
Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3.
Tumour Biol
; 36(4): 2631-40, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472579
5.
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
Anticancer Drugs
; 26(4): 371-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25514114
6.
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trials.
Acta Oncol
; 54(2): 187-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25017379
7.
Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.
Tumour Biol
; 35(10): 10237-48, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25027407
8.
Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment).
Anticancer Drugs
; 25(2): 212-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24201305
9.
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
Int J Cancer
; 132(1): 236-45, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22644776
10.
Early tumor shrinkage in metastatic colorectal cancer: retrospective analysis from an irinotecan-based randomized first-line trial.
Cancer Sci
; 104(6): 718-24, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23480146
11.
Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels.
Anticancer Drugs
; 24(9): 969-74, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23863616
12.
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trial.
Acta Oncol
; 52(5): 956-62, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23244709
13.
Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone.
Langenbecks Arch Surg
; 398(2): 265-76, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23314791
14.
Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis.
Anticancer Drugs
; 23(6): 666-73, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22441566
15.
Analysis of Circulating Immune Subsets in Primary Colorectal Cancer.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551592
16.
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
; 173: 194-203, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940054
17.
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
BMC Cancer
; 11: 367, 2011 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21861888
18.
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
Anticancer Drugs
; 22(9): 913-8, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21795973
19.
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
Eur J Cancer
; 157: 71-80, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507244
20.
[Update - Stage-dependent standards and innovations in the treatment of colorectal cancer]. / Therapie des kolorektalen Karzinoms - Neues und Bewährtes.
MMW Fortschr Med
; 166(10): 44-49, 2024 06.
Artículo
en Alemán
| MEDLINE | ID: mdl-38806923